4.5 Article

The Effect of Chronic Cerebral Hypoperfusion on Amyloid-β Metabolism in a Transgenic Mouse Model of Alzheimer's Disease (PS1V97L)

Journal

JOURNAL OF ALZHEIMERS DISEASE
Volume 62, Issue 4, Pages 1609-1621

Publisher

IOS PRESS
DOI: 10.3233/JAD-171094

Keywords

Alzheimer's disease; amyloid-beta; chronic cerebral hypoperfusion; metabolism; oligomers; transgenic mice

Categories

Funding

  1. National Natural Science Foundation of China [81530036]
  2. National Key Scientific Instrument and Equipment Development Project [31627803]
  3. Mission Program of Beijing Municipal Administration of Hospitals [SML20150801]
  4. Beijing Scholars Program
  5. Beijing Brain Initiative from Beijing Municipal Science & Technology Commission [Z161100000216137]
  6. CHINA-CANADA Joint Initiative on Alzheimer's Disease and Related Disorders [81261120571]
  7. Beijing Municipal Commission of Health and Family Planning [PXM2017_026283_000002]

Ask authors/readers for more resources

Alzheimer's disease (AD) and cerebrovascular disease often coexist. However, it is difficult to determine how chronic cerebral hypoperfusion affects the metabolism of amyloid-beta peptides (A beta) in a living patient with AD. Thus, we developed an animal model of this condition, using transgenic mice (PS1V97L) and right common carotid artery ligation to create chronic cerebral hypoperfusion. The metabolic processes associated with amyloid-beta peptide (A beta) were observed and evaluated in this PS1V97L plus hypoperfusion model. Compared with control mice, the model revealed significantly upregulated expression of A beta (including A beta oligomers), with decreased alpha-secretase activity and expression and increased beta-secretase activity and expression. Furthermore, the model revealed increased mRNA and protein expression of the receptor for advanced glycation end products (RAGE) and decreased mRNA and protein expression of low-density lipoprotein receptor-related protein 1 (LRP-1); both these are A beta transporters. Moreover, the model revealed decreased activity and expression of neprilysin, which is a peripheral A beta degrading enzyme. These findings suggest that hypoperfusion may magnify the effect of AD on A beta metabolism by aggravating its abnormal production, transport, and clearance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Neutrophil Extracellular Traps may be a Potential Target for Treating Early Brain Injury in Subarachnoid Hemorrhage

Hanhai Zeng, Xiongjie Fu, Jing Cai, Chenjun Sun, Mengyan Yu, Yucong Peng, Jianfeng Zhuang, Jingyin Chen, Huaijun Chen, Qian Yu, Chaoran Xu, Hang Zhou, Yang Cao, Libin Hu, Jianru Li, Shenglong Cao, Chi Gu, Feng Yan, Gao Chen

Summary: Neuroinflammation in patients with subarachnoid hemorrhage (SAH) is closely associated with poor prognosis, and neutrophil extracellular traps (NETs) play a key role in promoting inflammation. Inhibiting NET formation can attenuate the damage caused by neuroinflammation after SAH.

TRANSLATIONAL STROKE RESEARCH (2022)

Review Clinical Neurology

State-of-the-art of lumbar puncture and its place in the journey of patients with Alzheimer's disease

Harald Hampel, Leslie M. Shaw, Paul Aisen, Christopher Chen, Alberto Lleo, Takeshi Iwatsubo, Atsushi Iwata, Masahito Yamada, Takeshi Ikeuchi, Jianping Jia, Huali Wang, Charlotte E. Teunissen, Elaine Peskind, Kaj Blennow, Jeffrey Cummings, Andrea Vergallo

Summary: The article discusses the necessity and inconsistency of lumbar puncture in the diagnosis of Alzheimer's disease, highlighting the importance of lumbar puncture in early diagnosis and treatment.

ALZHEIMERS & DEMENTIA (2022)

Review Nutrition & Dietetics

B vitamins and prevention of cognitive decline and incident dementia: a systematic review and meta-analysis

Zhibin Wang, Wei Zhu, Yi Xing, Jianping Jia, Yi Tang

Summary: This meta-analysis suggests that B vitamin supplementation is associated with slowing of cognitive decline, especially in populations who received early intervention and intervention of long duration; the study also indicates that higher intake of dietary folate, but not B12 or B6, is associated with a reduced risk of incident dementia in non-dementia aged population.

NUTRITION REVIEWS (2022)

Correction Clinical Neurology

Inhibition of Dectin-1 Ameliorates Neuroinflammation by Regulating Microglia/Macrophage Phenotype After Intracerebral Hemorrhage in Mice (Feb, 10.1007/s12975-021-00889-2, 2021)

Xiongjie Fu, Hanhai Zeng, Jikuang Zhao, Guoyang Zhou, Hang Zhou, Jianfeng Zhuang, Chaoran Xu, Jianru Li, Yucong Peng, Yang Cao, Yin Li, Huaijun Chen, Lin Wang, Feng Yan, Gao Chen

TRANSLATIONAL STROKE RESEARCH (2022)

Article Clinical Neurology

The use of lumbar puncture and safety recommendations in Alzheimer's disease: a plain language summary

Harald Hampel, Aya Elhage, Leslie M. Shaw, Paul Aisen, Christopher Chen, Alberto Lleo, Takeshi Iwatsubo, Atsushi Iwata, Masahito Yamada, Takeshi Ikeuchi, Jianping Jia, Huali Wang, Charlotte E. Teunissen, Elaine Peskind, Kaj Blennow, Jeffrey Cummings, Andrea Vergallo

Summary: This article is a summary of the safe use of lumbar puncture in diagnosing Alzheimer's disease and other forms of dementia. Despite the low risk of complications, there may be reluctance among physicians and patients to recommend or undergo this procedure. Patient education, specialist training, and new methods for patient safety are important factors in supporting the widespread use of lumbar puncture in Alzheimer's disease.

NEURODEGENERATIVE DISEASE MANAGEMENT (2022)

Article Neurosciences

Serum Homocysteine, Vitamin B12, Folate, and Their Association with Mild Cognitive Impairment and Subtypes of Dementia

Yang Song, Meina Quan, Tingting Li, Jianping Jia

Summary: This study investigates the changes of homocysteine, vitamin B12, and folate levels in different subtypes of dementia and their associations with cognitive function and MRI markers. The results show that elevated homocysteine levels and lower vitamin B12 levels are associated with various types of dementia. Homocysteine levels are correlated with temporal lobe atrophy in Alzheimer's disease, while vitamin B12 levels are associated with general cognition in vascular dementia. Hyperhomocysteinemia may increase the risk of Alzheimer's disease, vascular dementia, and frontotemporal dementia.

JOURNAL OF ALZHEIMERS DISEASE (2022)

Article Neurosciences

A 19-Year-Old Adolescent with Probable Alzheimer's Disease

Jianping Jia, Yue Zhang, Yuqing Shi, Xuping Yin, Shiyuan Wang, Yan Li, Tan Zhao, Wenying Liu, Aihong Zhou, Longfei Jia

Summary: In this report, a case of a 19-year-old male with gradual memory decline for 2 years and characteristic neuroimaging and biomarker findings for Alzheimer's disease (AD) is presented. Despite the young age of the patient, the clinical presentation and diagnostic tests confirmed a probable diagnosis of AD.

JOURNAL OF ALZHEIMERS DISEASE (2023)

Article Medicine, General & Internal

Association between healthy lifestyle and memory decline in older adults: 10 year, population based, prospective cohort study

Jianping Jia, Tan Zhao, Zhaojun Liu, Yumei Liang, Fangyu Li, Yan Li, Wenying Liu, Fang Li, Shengliang Shi, Chunkui Zhou, Heyun Yang, Zhengluan Liao, Yang Li, Huiying Zhao, Jintao Zhang, Kunnan Zhang, Minchen Kan, Shanshan Yang, Hao Li, Zhongling Liu, Rong Ma, Jihui Lv, Yue Wang, Xin Yan, Furu Liang, Xiaoling Yuan, Jinbiao Zhang, Serge Gauthier, Jeffrey Cummings

Summary: This study aimed to identify an optimal lifestyle profile for protecting older individuals from memory loss. The findings revealed that a healthy lifestyle is associated with slower memory decline, even in the presence of the APOE epsilon 4 allele. This study offers important information to protect older adults against memory decline.

BMJ-BRITISH MEDICAL JOURNAL (2023)

Article Clinical Neurology

Unsupervised machine learning model to predict cognitive impairment in subcortical ischemic vascular disease

Qi Qin, Junda Qu, Yunsi Yin, Ying Liang, Yan Wang, Bingxin Xie, Qingqing Liu, Xuan Wang, Xinyi Xia, Meng Wang, Xu Zhang, Jianping Jia, Yi Xing, Chunlin Li, Yi Tang

Summary: An unsupervised machine learning model was developed to predict the risk of progression from subcortical ischemic vascular disease (SIVD) to subcortical vascular cognitive impairment (SVCI). The model achieved high accuracy, sensitivity, and specificity and can be applied to other cohorts and clinical practice.

ALZHEIMERS & DEMENTIA (2023)

Article Neurosciences

Upregulation of Wnt2b exerts neuroprotective effect by alleviating mitochondrial dysfunction in Alzheimer's disease

Ling-Zhi Xu, Bing-Qiu Li, Fang-Yu Li, Mei-Na Quan, Wei Qin, Ying Li, Wen-Wen Li, Yu Zhao, Yi-Ping Wei, Jian-Ping Jia

Summary: This study investigated the relationship between plasma Wnt2b levels and Alzheimer's disease (AD) and found that Wnt2b decline is associated with cognitive impairment in AD. Upregulation of Wnt2b can effectively prevent downregulation of canonical Wnt signaling, mitochondrial dysfunction, intracellular calcium overload, and neuronal damage in AD.

CNS NEUROSCIENCE & THERAPEUTICS (2023)

Article Neurosciences

Betaine Mitigates Amyloid-beta-Associated Neuroinflammation by Suppressing the NLRP3 and NF-kappa B Signaling Pathways in Microglial Cells

Yue Zhang, Jianping Jia

Summary: In this study, betaine was found to inhibit AβO-induced neuroinflammation in microglia by suppressing the activation of the NLRP3 inflammasome and NF-κB, suggesting its potential as an effective modulator for AD.

JOURNAL OF ALZHEIMERS DISEASE (2023)

Article Clinical Neurology

Shared and unique effects of ApoEε4 and pathogenic gene mutation on cognition and imaging in preclinical familial Alzheimer's disease

Meina Quan, Qi Wang, Wei Qin, Wei Wang, Fangyu Li, Tan Zhao, Tingting Li, Qiongqiong Qiu, Shuman Cao, Shiyuan Wang, Yan Wang, Hongmei Jin, Aihong Zhou, Jiliang Fang, Longfei Jia, Jianping Jia

Summary: This study investigated the effects of APOE epsilon 4 and known pathogenic gene mutation on cognitive domains and circuit imaging markers in preclinical familial Alzheimer's disease (FAD). Neuropsychological tests and MRI scanning were conducted on 139 asymptomatic subjects, revealing changes in hippocampal volume, functional connectivity, and diffusion indices in the genetic groups compared to controls. These findings contribute to the early identification and development of preventive strategies for Alzheimer's disease.

ALZHEIMERS RESEARCH & THERAPY (2023)

Article Oncology

A blood-based composite panel that screens Alzheimer's disease

Yan Wang, Ying Li, Yan Li, Tingting Li, Qi Wang, Qigeng Wang, Shuman Cao, Fangyu Li, Jianping Jia

Summary: This study selected four potential biomarkers and measured their plasma levels in patients with Alzheimer's disease and amnestic mild cognitive impairment, developing a composite panel for screening and diagnosing these two conditions.

BIOMARKER RESEARCH (2023)

Article Medicine, General & Internal

Aberrant palmitoylation caused by a ZDHHC21 mutation contributes to pathophysiology of Alzheimer's disease

Wenwen Li, Yana Pang, Yan Wang, Fan Mei, Mengmeng Guo, Yiping Wei, Xinyue Li, Wei Qin, Wei Wang, Longfei Jia, Jianping Jia

Summary: This study identified a novel Chinese familial Alzheimer's disease (FAD) causal gene mutation, ZDHHC21 p.T209S, which leads to aberrant protein palmitoylation and contributes to the pathogenesis of AD. These findings provide new insights for further investigation and development of therapeutic interventions.

BMC MEDICINE (2023)

Review Health Care Sciences & Services

Post-COVID cognitive dysfunction: current status and research recommendations for high risk population

Meina Quan, Xuechu Wang, Min Gong, Qi Wang, Yan Li, Jianping Jia

Summary: PCCD is a condition in which patients with a history of SARS-CoV-2 infection develop cognitive impairment in various domains. Understanding the risk factors and management strategies of PCCD is important for disease management. This paper reviews epidemiology, diagnostic markers, risk factors, and available treatments for PCCD.

LANCET REGIONAL HEALTH-WESTERN PACIFIC (2023)

No Data Available